Insider Transactions in Q1 2021 at Protagonist Therapeutics, Inc (PTGX)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 26
2021
|
Suneel Gupta Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+15.79%
|
-
|
|
Feb 26
2021
|
Donald A. Kalkofen Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+41.93%
|
-
|
|
Feb 26
2021
|
David Y Liu Chief R&D Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+13.81%
|
-
|
|
Feb 26
2021
|
Dinesh V Ph D Patel President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+5.25%
|
-
|
|
Feb 26
2021
|
Samuel R Saks Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+46.15%
|
-
|
|
Feb 11
2021
|
Sarah B. Noonberg Director |
SELL
Open market or private sale
|
Direct |
3,700
-100.0%
|
$92,500
$25.09 P/Share
|
|
Feb 11
2021
|
Sarah B. Noonberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,700
+50.0%
|
$22,200
$6.98 P/Share
|
|
Feb 10
2021
|
Sarah B. Noonberg Director |
SELL
Open market or private sale
|
Direct |
4,700
-95.74%
|
$117,500
$25.73 P/Share
|
|
Feb 10
2021
|
Sarah B. Noonberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,700
+50.0%
|
$28,200
$6.98 P/Share
|
|
Jan 19
2021
|
Dinesh V Ph D Patel President and CEO |
SELL
Open market or private sale
|
Direct |
24,846
-5.51%
|
$596,304
$24.6 P/Share
|
|
Jan 19
2021
|
Dinesh V Ph D Patel President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,000
+2.8%
|
$52,000
$4.21 P/Share
|